MedPath

Bisacodyl

Generic Name
Bisacodyl
Brand Names
Alophen Reformulated Jan 2008, Bi-peglyte, Bisac-evac, Carters Little Pills, Dulcolax, Fleet Mineral Oil, Gavilyte-H and Bisacodyl
Drug Type
Small Molecule
Chemical Formula
C22H19NO4
CAS Number
603-50-9
Unique Ingredient Identifier
10X0709Y6I
Background

Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).

Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.

Indication

Bisacodyl is indicated to relieve occasional constipation and irregularity.

Associated Conditions
Bowel movement irregularity, Constipation, Occasional Constipation
Associated Therapies
Bowel preparation therapy

Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep

Phase 3
Completed
Conditions
Bowel Preparation
Interventions
First Posted Date
2010-02-23
Last Posted Date
2012-10-30
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
603
Registration Number
NCT01073943
Locations
🇺🇸

Florida Clinical Research Group, Clearwater, Florida, United States

🇺🇸

Gastroenterology Research Consultants of Greater Cincinnati, Cincinnati, Ohio, United States

🇺🇸

Investigational site, Hollywood, Florida, United States

and more 8 locations

Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep

Phase 3
Completed
Conditions
Bowel Preparation
Interventions
First Posted Date
2010-02-23
Last Posted Date
2013-02-12
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
608
Registration Number
NCT01073930
Locations
🇺🇸

Louisiana Research Center LLC, Shreveport, Louisiana, United States

🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

🇺🇸

Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States

and more 6 locations

Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation

Phase 4
Completed
Conditions
Preparation for Colonoscopy
Interventions
Drug: Gatorade/Miralax
Drug: Placebo
First Posted Date
2010-02-05
Last Posted Date
2013-11-18
Lead Sponsor
Gastroenterology Services, Ltd.
Target Recruit Count
600
Registration Number
NCT01063049
Locations
🇺🇸

Gastroenterology Services, Downers Grove, Illinois, United States

Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients

Phase 2
Completed
Conditions
Postoperative Nausea and Vomiting
Abdominal Pain
Interventions
Drug: placebo
First Posted Date
2009-11-11
Last Posted Date
2014-01-20
Lead Sponsor
The Cooper Health System
Target Recruit Count
285
Registration Number
NCT01011426
Locations
🇺🇸

Cooper University Hospital, Camden, New Jersey, United States

A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

First Posted Date
2009-08-06
Last Posted Date
2012-11-30
Lead Sponsor
Brooke Army Medical Center
Target Recruit Count
425
Registration Number
NCT00953017
Locations
🇺🇸

Brooke Army Medical Center, San Antonio, Texas, United States

Dulcolax vs Placebo in Functional Constipation

Phase 3
Completed
Conditions
Constipation
Interventions
First Posted Date
2007-09-06
Last Posted Date
2014-01-15
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
368
Registration Number
NCT00526097
Locations
🇬🇧

122.56.44011 Boehringer Ingelheim Investigational Site, Bedworth, United Kingdom

🇬🇧

122.56.44032 Boehringer Ingelheim Investigational Site, Addlestone, United Kingdom

🇬🇧

122.56.44018 Boehringer Ingelheim Investigational Site, Ash Vale, Aldershot, United Kingdom

and more 24 locations

Randomized Clinical Trial of Bisacodyl Versus Placebo on Postoperative Bowel Motility in Elective Colorectal Surgery

Phase 4
Completed
Conditions
Postoperative Ileus
Interventions
Drug: glucosemonohydricum
First Posted Date
2007-07-31
Last Posted Date
2007-07-31
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
200
Registration Number
NCT00509327
Locations
🇨🇭

Department of Surgery, Triemli Hospital, Zurich, Switzerland, Zurich, Switzerland

A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy

Phase 4
Completed
Conditions
Colonoscopy
Interventions
First Posted Date
2006-12-12
Last Posted Date
2015-09-22
Lead Sponsor
Queen's University
Target Recruit Count
315
Registration Number
NCT00410215
Locations
🇨🇦

Hotel Dieu Hospital, Kingston, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath